330728P

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

Avanti Research^™ - A Croda Brand

• Synonyme(s) : D-galactosyl-β-1,1′-N-tridecanoyl-D-erythro-sphingosine-d7
• Formule empirique (notation de Hill): C₃₇H₆₄D₇NO₈
• Numéro CAS: 2315262-19-0
• Poids moléculaire : 665.00
• Numéro MDL: MFCD35064284
• Code UNSPSC : 12352211
• Nomenclature NACRES : NA.12

Propriétés

• Essai: 99% (TLC)
• Forme: powder
• Conditionnement: pkg of 1 × 1 mg (330728P-1MG)
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand
• Conditions d'expédition: dry ice
• Température de stockage: −20°C
• Chaîne SMILES: [H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO
• InChI: 1S/C37H71NO8/c1-3-5-7-9-11-13-15-16-17-18-20-22-24-26-31(40)30(29-45-37-36(44)35(43)34(42)32(28-39)46-37)38-33(41)27-25-23-21-19-14-12-10-8-6-4-2/h24,26,30-32,34-37,39-40,42-44H,3-23,25,27-29H2,1-2H3,(H,38,41)/b26-24+/t30-,31+,32+,34-,35-,36+,37+/m0/s1/i1
• Clé InChI: KJMFYHPLIHBVNV-SXOXVQABSA-N

Description

Description générale

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0) is deuterated derivative of C13 Galactosyl(β) Ceramide. β-Galactosyl ceramide (β −GalCer) is one of the uncomplicated glycosphingolipid. It contains a lipophilic sphingosine and a hydrophilic galactose moiety, which is attached to sphingosine via an ether linkage. It is localized in the myelin sheath of the peripheral and central nervous system.

Actions biochimiques/physiologiques

β-Galactosyl ceramide (β −GalCer) plays a role in regulating the activity of β-glucocerebrosidase (β-GlcCer′ase). It is also a receptor for various bacterial and viral toxins.

Conditionnement

5 mL Amber Glass Screw Cap Vial

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable